FROVATRIPTAN Drug Patent Profile
✉ Email this page to a colleague
When do Frovatriptan patents expire, and what generic alternatives are available?
Frovatriptan is a drug marketed by Amneal Pharms Co, Glenmark Pharms Ltd, Leading, Pharmobedient, and Renata. and is included in five NDAs.
The generic ingredient in FROVATRIPTAN is frovatriptan succinate. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the frovatriptan succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Frovatriptan
A generic version of FROVATRIPTAN was approved as frovatriptan succinate by GLENMARK PHARMS LTD on March 11th, 2016.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FROVATRIPTAN?
- What are the global sales for FROVATRIPTAN?
- What is Average Wholesale Price for FROVATRIPTAN?
Summary for FROVATRIPTAN
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Drug Prices: | Drug price information for FROVATRIPTAN |
| DailyMed Link: | FROVATRIPTAN at DailyMed |
US Patents and Regulatory Information for FROVATRIPTAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharms Co | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 211292-001 | Nov 6, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharmobedient | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 202931-001 | Aug 28, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glenmark Pharms Ltd | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 204730-001 | Mar 11, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Leading | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 216998-001 | Apr 16, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Renata | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 213891-001 | Apr 6, 2022 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
